2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Calcinosis: new trials by email Literature Review of Calcinosis trials Research Report on Calcinosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis Topical 25% sodium metabisulfite (SM) in pediatric cold cream, Placebo - Systemic Sclerosis, Calcinosis | Phase 1 / Phase 2 | Unknown | Pontificia Universidad Catolica de Chile | 20 | 2024-01-02 | 2023-12-04 |
| The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH Rifampin 150 mg, 300 mg capsules and 25 mg/mL oral suspension - Idiopathic Infantile Hypercalcemia - Mild Form | Phase 1 | Unknown | The Hospital for Sick Children | 5 | 2018-02-22 | 2021-08-31 |
Hypercalcemia (1) · Hypercalciuria (1) · Nephrocalcinosis (1) · Scleroderma, Systemic (1)
Calcium Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Connective Tissue Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Rifampin (1) · Suspensions (1) · sodium metabisulfite (1)
Pontificia Universidad Catolica de Chile (1) · The Hospital for Sick Children (1)
Canada (1) · Chile (1)